APLS — Apellis Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $5.25bn
- $5.30bn
- $1.00bn
Apellis Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Apellis Pharmaceuticals Q1 Basic EPS USD -0.54
Apellis Pharmaceuticals Inc expected to post a loss of 52 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Bark, Fleetcor Technologies, Tesla
Apellis Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Brief: Apellis Pharmaceuticals Q4 Basic EPS USD -0.73
Apellis Pharmaceuticals Inc expected to post a loss of 69 cents a share - Earnings Preview
Apellis Pharmaceuticals Inc expected to post a loss of 69 cents a share - Earnings Preview
Brief: Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP-Apellis Pharmaceuticals, Saia, Tesla
U.S. STOCKS ON THE MOVE-Intel, American Express, Spirit Airlines
U.S. STOCKS ON THE MOVE-Estee Lauder, L3Harris Technologies, Booz Allen
U.S. STOCKS ON THE MOVE-American Express, Colgate-Palmolive, BowFlex
Brief: Apellis Pharmaceuticals Plans To Seek Immediate Re-Examination Of Its Application
Apellis falls on EMA's negative opinion of eye drug
U.S. RESEARCH ROUNDUP-Burlington Stores, Carrols Restaurant Group, Mastec
Apellis climbs as brokerages raise PT on prelim Q4 eye drug sales
Brief: Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
U.S. RESEARCH ROUNDUP- Carlisle Companies, Fedex, Nike